First Graphene Limited

First Graphene Limited engages in the research, development, mining, exploration, manufacture, and sale of graphene products in Australia. It operates through Graphene Production, Research and Development, and Mining Asset Maintenance segments. The company offers MB-LDPE graphene enhanced masterbatch, MB-EVA graphene enhanced masterbatch, MB-EVA bitumen graphene enhanced masterbatch, aqua pre-dispersed graphene additives, and nanoplatelet additives under the PureGRAPH brand. The company also develops and sells VFD, TTF, and other 2D devices and materials. Its products are used in the coating and inks, composite, elastomer, fire retardancy, concrete, textile, and energy storage applications. First Graphene Limited is headquartered in Henderson, Australia.

First Graphene Limited trades as FGPHF on OTC. The company is classified in Basic Materials / Chemicals and reports in USD.

The current profile places the business in Chemicals. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows $468,397 of revenue and -$5.48M of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

First Graphene Limited can be compared against peers such as Blue Biofuels, Inc., BioLargo, Inc., Black Swan Graphene Inc., E3 Lithium Limited, Oceanic Iron Ore Corp., Galway Metals Inc..

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $41.39M, beta of 0.96, and return on equity of -122.0%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

FGPHF currently shows total debt of $3.07M and beta of 0.96. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.firstgraphene.net

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.